Medication info

Paltaramadol Injection (Tramadol Hydrochloride)

Prescription medicationInjectionsIntramuscular injection · Intravenous injectionApproval withdrawn
Ingredient · strength
Tramadol Hydrochloride›50mg / 1 ampoule
Manufacturer / importer
Pharma Research Co., Ltd.
Appearance
A colorless and transparent liquid in a brown ampoule injection.
Packaging
50 ampoules/box [(1 milliliter/ampoule)]
Approval status
Approval withdrawn

MFDS item code 202106253 · Notified 2021.08.31

This product's status changed to Approval withdrawn on 2026.02.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Relief of post-diagnostic and postoperative pain, and moderate to severe acute and chronic pain (e.g., cancer pain)
Who receives it
Adults
Adult administration
The dose of this medicine should be adjusted according to the patient's pain intensity and clinical response. In general, administer the lowest dose that relieves pain. Adults Administer tramadol hydrochloride 50-100mg per dose by intravenous or intramuscular injection, then repeat every 4-5 hours as needed. A maximum of 400mg may be administered per day. Elderly patients No dose adjustment is necessary in patients 75 years of age or younger who have no clinically confirmed hepatic or renal impairment. In patients over 75 years of age, excretion of this medicine may be delayed; adjust the dosing interval as needed. Patients with renal impairment/on dialysis or patients with hepatic impairment In patients with renal or hepatic impairment, excretion of this medicine may be delayed; therefore, consider extending the dosing interval in these patients.

Ingredients

Manufacturer
Pharma Research Co., Ltd.

Efficacy & effects

Relief of post-diagnostic and postoperative pain, and moderate to severe acute and chronic pain (e.g., cancer pain)

  • Severe and moderate acute chronic pain
  • various cancer pains
  • postoperative pain
  • pain after diagnosis.
View approved original text

This medication is used for the relief of severe and moderate acute chronic pain, such as pain arising from various cancers or pain occurring after diagnosis and surgery.

How it is given

Adult administration

The dose of this medicine should be adjusted according to the patient's pain intensity and clinical response. In general, administer the lowest dose that relieves pain. Adults Administer tramadol hydrochloride 50-100mg per dose by intravenous or intramuscular injection, then repeat every 4-5 hours as needed. A maximum of 400mg may be administered per day. Elderly patients No dose adjustment is necessary in patients 75 years of age or younger who have no clinically confirmed hepatic or renal impairment. In patients over 75 years of age, excretion of this medicine may be delayed; adjust the dosing interval as needed. Patients with renal impairment/on dialysis or patients with hepatic impairment In patients with renal or hepatic impairment, excretion of this medicine may be delayed; therefore, consider extending the dosing interval in these patients.

Precautions

This medication should be taken at the recommended dosage, as exceeding it may cause seizures. Patients with a history of epilepsy or risk of seizures should use this medication only when necessary. Long-term use may lead to psychological and physical dependence; thus, patients with a history of drug abuse or dependence should use it for a short duration only. Caution is advised when combined with alcohol or central nervous system depressants, as it may lead to severe drowsiness, respiratory depression, or coma. Some patients may metabolize this medication very quickly, leading to unexpected severe side effects, necessitating special monitoring. This medication should not be used in children under 12 years of age or adolescents under 18 years who've had a tonsillectomy or adenoidectomy. Care should be taken to avoid glass fragments when using the injection, especially in children and the elderly. It should not be used in patients with acute alcohol poisoning, severe respiratory depression, severe liver or kidney disorders, pregnant or breastfeeding women, or patients taking certain medications. Caution is also required for patients using morphine, those with liver or kidney disorders, and those who consume alcohol, as well as those with a history of seizures. Drowsiness and dizziness may occur while taking this medication, so driving or operating dangerous machinery should be avoided. Additionally, it’s important to taper the dosage gradually to prevent withdrawal symptoms after discontinuation. This medication may interact with various drugs; therefore, discussions with healthcare providers regarding concurrent medications are crucial. Pregnant or breastfeeding women should avoid its use, particularly during breastfeeding due to the potential for serious side effects in the infant. For elderly patients, a lower dosage is advised for safety. In cases of overdose, severe respiratory depression and seizures may occur, requiring immediate emergency treatment, with naloxone potentially being used as an antidote. This medication must be stored according to the specified storage instructions, out of reach of children.

Side effects

  • Convulsions
  • seizures
  • hypersensitivity
  • shock
  • anaphylaxis
  • itching
  • hives
  • bronchospasm
  • angioedema
  • respiratory depression
Show 80 more
  • dyspnea
  • asthma exacerbation
  • hiccups
  • palpitations
  • coldness
  • mimicry concerns
  • vasodilation
  • hypotension
  • arrhythmia
  • facial pallor
  • syncope
  • orthostatic hypotension
  • tachycardia
  • bradycardia
  • hypertension
  • drowsiness
  • sleep
  • headache
  • heaviness in the head
  • agitation
  • tremor
  • tinnitus
  • numbness in both hands
  • anxiety
  • collapse
  • fatigue
  • lethargy
  • sweating
  • dizziness
  • staggering
  • discomfort
  • dysuria
  • dry mouth
  • thirst
  • confusion
  • coordination impairment
  • akathisia
  • restlessness
  • sleep disorder
  • cognitive impairment
  • hallucinations
  • amnesia
  • concentration impairment
  • depression
  • changes in appetite
  • sensory abnormality
  • epileptic seizures
  • involuntary muscle contractions
  • muscle weakness
  • urinary retention
  • frequent urination
  • menopausal syndrome
  • urination disorders
  • menstrual disorders
  • herpes zoster
  • Stevens-Johnson syndrome
  • sweating
  • skin reactions
  • allergic reactions
  • fever
  • warmth
  • chills
  • cold sensation
  • visual disturbances
  • taste disturbances
  • weight loss
  • injection site irritation
  • agitation
  • insomnia
  • hyperactivity
  • panic attacks
  • severe anxiety
  • sensory abnormalities
  • miosis
  • vomiting
  • cardiovascular collapse
  • loss of consciousness
  • coma
  • convulsions
  • dyspnea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that protects it from light, at a safe temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

A colorless and transparent liquid in a brown ampoule injection.

Package unit

50 ampoules/box [(1 milliliter/ampoule)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.